Exelixis (EXEL) 30-day volatility at 106 compared to 60 from a month ago

September 28, 2016 12:19 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Exelixis (NASDAQ: EXEL) is recently down 17% on cabozantinib and Opdivo data concerns. 30-day call option implied volatility of 106 compares to volatility of 60 from a month ago.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Options, Trader Talk

Related Entities

Options

Add Your Comment